SEC Form 4 · accession 0001382963-17-000186
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 8:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Shares | Dec 11, 2017 | S | 20,000 | $0.172 | D | 26,263,122 | D | |
| INVO Bioscience Common Shares | Dec 11, 2017 | S | 20,000 | $0.1781 | D | 26,243,122 | D | |
| INVO Bioscience Common Shares | Dec 11, 2017 | S | 10,000 | $0.18 | D | 26,233,122 | D |
Table II — derivative securities
No Table II lines on this filing.